Literature DB >> 20471567

Oncocytic adrenocortical carcinoma.

Hiroya Ohtake1, Hiroshi Kawamura, Masami Matsuzaki, Eiichi Yokoyama, Masayuki Kitajima, Shiro Onizuka, Mitsunori Yamakawa.   

Abstract

Only 17 cases of oncocytic adrenocortical carcinoma have been reported in the English literature. Here, we report an incidental case of oncocytic adrenocortical carcinoma. The patient was a 69-year-old man with the chief complaint of abdominal pain. Abdominal computed tomography revealed a left adrenal tumor. No hormonal symptoms were observed. The excised tumor was whitish, encapsulated, and 75 x 60 x 45 mm in size. Large polygonal tumor cells were arranged in a generally diffuse architecture and exhibited abundant eosinophilic granular cytoplasm. Nuclear atypia with atypical mitotic figures and capsular and sinusoidal invasions were observed. The tumor cells were immunopositive for vimentin, neuron-specific enolase, and synaptophysin but not for alpha-inhibin, melan A, or p53. Diffuse and strong immunopositivity with an antimitochondrial antibody proved that this tumor was truly oncocytic. Upon review of previous cases of oncocytic adrenocortical tumors, we reconsidered the diagnostic findings of the potential for malignancy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20471567     DOI: 10.1016/j.anndiagpath.2009.06.006

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  10 in total

1.  Bilateral adrenocortical oncocytoma with bilateral myelolipomatous metaplasia.

Authors:  Charu Shastri; Chanchal Rana; Niraj Kumari; Gaurav Agarwal; Narendra Krishnani
Journal:  Endocr Pathol       Date:  2012-06       Impact factor: 3.943

Review 2.  Adrenocortical carcinoma.

Authors:  Tobias Else; Alex C Kim; Aaron Sabolch; Victoria M Raymond; Asha Kandathil; Elaine M Caoili; Shruti Jolly; Barbra S Miller; Thomas J Giordano; Gary D Hammer
Journal:  Endocr Rev       Date:  2013-12-20       Impact factor: 19.871

3.  Large oncocytic adrenocortical tumor with uncertain malignant potential.

Authors:  Chang Ki Lee; Kyung Hwa Choi; Yoon Jin Cha; Jung Ha Bum; Hyung Ho Lee; Myung Soo Kim; Won Kyu Park; Seung Choul Yang; Woong Kyu Han
Journal:  Korean J Urol       Date:  2011-09-28

Review 4.  Oncocytic mania: a review of oncocytic lesions throughout the body.

Authors:  F Guaraldi; G Zang; A P Dackiw; P Caturegli
Journal:  J Endocrinol Invest       Date:  2011-02-07       Impact factor: 4.256

5.  Oncocytic adrenocortical tumor with uncertain malignant potential in pediatric population: A case report and review of literature.

Authors:  Xiao-Chun Chen; Yun-Man Tang; Yu Mao; Dao-Rui Qin
Journal:  World J Clin Cases       Date:  2021-07-16       Impact factor: 1.337

Review 6.  Adrenocortical neoplasia: evolving concepts in tumorigenesis with an emphasis on adrenal cortical carcinoma variants.

Authors:  Ronald R de Krijger; Thomas G Papathomas
Journal:  Virchows Arch       Date:  2011-11-16       Impact factor: 4.064

7.  A Case of Oncocytic Adrenocortical Neoplasm of Borderline (Uncertain) Malignant Potential.

Authors:  Mina Shenouda; Linda G Brown; Krista L Denning; Toni Pacioles
Journal:  Cureus       Date:  2016-06-13

Review 8.  Laparoscopic Trans-Abdominal Right Adrenalectomy for a Large Primitive Adrenal Oncocytic Carcinoma: A Case Report and Review of Literature.

Authors:  Valerio Panizzo; Barbara Rubino; Guglielmo Niccolò Piozzi; Paolo Ubiali; Anna Morandi; Marco Nencioni; Giancarlo Micheletto
Journal:  Am J Case Rep       Date:  2018-09-15

Review 9.  Adrenocortical Carcinoma: Updates of Clinical and Pathological Features after Renewed World Health Organisation Classification and Pathology Staging.

Authors:  Alfred King-Yin Lam
Journal:  Biomedicines       Date:  2021-02-10

10.  Ectopic functioning adrenocortical oncocytic adenoma (oncocytoma) with myelolipoma causing virilization.

Authors:  Lea F Surrey; Ashesh A Thaker; Paul J Zhang; Giorgos Karakousis; Michael D Feldman
Journal:  Case Rep Pathol       Date:  2012-10-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.